AMANDA GRAFF: Open Payments
NPI 1265165948 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,378 in 57 payments from 13 companies in 2025. Trend: 2023 $107 · 2024 $735 · 2025 $1,378
Food & beverage: $1,378
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $311 |
| Antares Pharma, Inc. | 16 | $249 |
| Merck Sharp & Dohme LLC | 9 | $187 |
| Boston Scientific Corporation | 1 | $147 |
| Janssen Biotech, Inc. | 4 | $102 |
| Ferring Pharmaceuticals Inc. | 3 | $87 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $83 |
| Dendreon Pharmaceuticals LLC | 3 | $63 |
| Astellas Pharma US Inc | 2 | $49 |
| Endo USA, Inc. | 2 | $43 |
Products named: XYOSTED, GEMTESA, KEYTRUDA, AMS 700, ERLEADA, ADSTILADRIN, JOURNAVX, Xtandi.
Industry payments across NY — which companies pay providers there.
